Trubion Royalties. Subject to Section 9.5(e), if Trubion has exercised its Opt-Out Option pursuant to Section 7.2, Facet shall pay Trubion royalties on the Net Sales of Royalty Products during the applicable Royalty Period as follows:
Appears in 2 contracts
Samples: Collaboration and License Agreement (Trubion Pharmaceuticals, Inc), Collaboration and License Agreement (Trubion Pharmaceuticals, Inc)
Trubion Royalties. Subject to Section 9.5(e), if Trubion has is deemed pursuant to Section 14.2(b) to have exercised its Opt-Out Option pursuant with respect to Section 7.2all Products on account of an uncured material breach by Trubion, Facet shall pay Trubion royalties on the Net Sales of Royalty Products during the applicable Royalty Period Period, as follows:
Appears in 1 contract
Samples: Collaboration and License Agreement (Trubion Pharmaceuticals, Inc)
Trubion Royalties. Subject to Section 9.5(e), if Trubion has exercised its Opt-Out Option pursuant to Section 7.2, Facet shall pay Trubion royalties on the Net Sales of Royalty Products during the applicable Royalty Period as follows:: Date of Trubion Opt-Out Notice: Royalty Rate: [ * ] [ * ] [ * ] [ * ] [ * ] [ * ]
Appears in 1 contract
Samples: Collaboration and License Agreement (Facet Biotech Corp)
